104 related articles for article (PubMed ID: 38945552)
21. Importance of cyclophosphamide-induced bystander effect on T cells for a successful tumor eradication in response to adoptive immunotherapy in mice.
Proietti E; Greco G; Garrone B; Baccarini S; Mauri C; Venditti M; Carlei D; Belardelli F
J Clin Invest; 1998 Jan; 101(2):429-41. PubMed ID: 9435316
[TBL] [Abstract][Full Text] [Related]
22. Th17 cells are refractory to senescence and retain robust antitumor activity after long-term ex vivo expansion.
Bowers JS; Nelson MH; Majchrzak K; Bailey SR; Rohrer B; Kaiser AD; Atkinson C; Gattinoni L; Paulos CM
JCI Insight; 2017 Mar; 2(5):e90772. PubMed ID: 28289713
[TBL] [Abstract][Full Text] [Related]
23. Adoptive transfer of cytotoxic T lymphocytes targeting two different antigens limits antigen loss and tumor escape.
Kaluza KM; Kottke T; Diaz RM; Rommelfanger D; Thompson J; Vile R
Hum Gene Ther; 2012 Oct; 23(10):1054-64. PubMed ID: 22734672
[TBL] [Abstract][Full Text] [Related]
24. Recovery Profiles of T-Cell Subsets Following Low-Dose Total Body Irradiation and Improvement With Cinnamon.
Zheng X; Guo Y; Wang L; Zhang H; Wang S; Wang L; An L; Zhou X; Li X; Yao C
Int J Radiat Oncol Biol Phys; 2015 Dec; 93(5):1118-26. PubMed ID: 26475064
[TBL] [Abstract][Full Text] [Related]
25. Cyclophosphamide induces dynamic alterations in the host microenvironments resulting in a Flt3 ligand-dependent expansion of dendritic cells.
Salem ML; Al-Khami AA; El-Naggar SA; Díaz-Montero CM; Chen Y; Cole DJ
J Immunol; 2010 Feb; 184(4):1737-47. PubMed ID: 20083664
[TBL] [Abstract][Full Text] [Related]
26. Host conditioning with IL-1β improves the antitumor function of adoptively transferred T cells.
Lee PH; Yamamoto TN; Gurusamy D; Sukumar M; Yu Z; Hu-Li J; Kawabe T; Gangaplara A; Kishton RJ; Henning AN; Vodnala SK; Germain RN; Paul WE; Restifo NP
J Exp Med; 2019 Nov; 216(11):2619-2634. PubMed ID: 31405895
[TBL] [Abstract][Full Text] [Related]
27. Prevention of interleukin-2 withdrawal-induced apoptosis in lymphocytes retrovirally cotransduced with genes encoding an antitumor T-cell receptor and an antiapoptotic protein.
Kalbasi A; Shrimali RK; Chinnasamy D; Rosenberg SA
J Immunother; 2010 Sep; 33(7):672-83. PubMed ID: 20664359
[TBL] [Abstract][Full Text] [Related]
28. Agonistic antibody to CD40 boosts the antitumor activity of adoptively transferred T cells in vivo.
Liu C; Lewis CM; Lou Y; Xu C; Peng W; Yang Y; Gelbard AH; Lizée G; Zhou D; Overwijk WW; Hwu P
J Immunother; 2012 Apr; 35(3):276-82. PubMed ID: 22421945
[TBL] [Abstract][Full Text] [Related]
29. Vaccination with CD133(+) melanoma induces specific Th17 and Th1 cell-mediated antitumor reactivity against parental tumor.
Miyabayashi T; Kagamu H; Koshio J; Ichikawa K; Baba J; Watanabe S; Tanaka H; Tanaka J; Yoshizawa H; Nakata K; Narita I
Cancer Immunol Immunother; 2011 Nov; 60(11):1597-608. PubMed ID: 21691723
[TBL] [Abstract][Full Text] [Related]
30. Recovery from cyclophosphamide-induced lymphopenia results in expansion of immature dendritic cells which can mediate enhanced prime-boost vaccination antitumor responses in vivo when stimulated with the TLR3 agonist poly(I:C).
Salem ML; Díaz-Montero CM; Al-Khami AA; El-Naggar SA; Naga O; Montero AJ; Khafagy A; Cole DJ
J Immunol; 2009 Feb; 182(4):2030-40. PubMed ID: 19201856
[TBL] [Abstract][Full Text] [Related]
31. Effector cells derived from naive T cells used in tumor immunotherapy of mice bearing B16 melanoma.
Wen M; Xu W; Ren L; Gao F; Cui N; Wen J; Li X; Lin L; Ma Z; Chen B; Cai J
Chin Med J (Engl); 2014; 127(7):1328-33. PubMed ID: 24709189
[TBL] [Abstract][Full Text] [Related]
32. Enhanced local and systemic anti-melanoma CD8+ T cell responses after memory T cell-based adoptive immunotherapy in mice.
Contreras A; Sen S; Tatar AJ; Mahvi DA; Meyers JV; Srinand P; Suresh M; Cho CS
Cancer Immunol Immunother; 2016 May; 65(5):601-11. PubMed ID: 27011014
[TBL] [Abstract][Full Text] [Related]
33. Adoptive transfer of ex vivo-activated memory T-cell subsets with cyclophosphamide provides effective tumor-specific chemoimmunotherapy of advanced metastatic murine melanoma and carcinoma.
Gold JE; Zachary DT; Osband ME
Int J Cancer; 1995 May; 61(4):580-6. PubMed ID: 7759164
[TBL] [Abstract][Full Text] [Related]
34. Th17 Cells Paradoxical Roles in Melanoma and Potential Application in Immunotherapy.
Chen C; Gao FH
Front Immunol; 2019; 10():187. PubMed ID: 30800130
[TBL] [Abstract][Full Text] [Related]
35. Complete regression of advanced primary and metastatic mouse melanomas following combination chemoimmunotherapy.
Kohlmeyer J; Cron M; Landsberg J; Bald T; Renn M; Mikus S; Bondong S; Wikasari D; Gaffal E; Hartmann G; Tüting T
Cancer Res; 2009 Aug; 69(15):6265-74. PubMed ID: 19622767
[TBL] [Abstract][Full Text] [Related]
36. B cells imprint adoptively transferred CD8
Smith AS; Knochelmann HM; Wyatt MM; Rangel Rivera GO; Rivera-Reyes AM; Dwyer CJ; Ware MB; Cole AC; Neskey DM; Rubinstein MP; Liu B; Thaxton JE; Bartee E; Paulos CM
J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35017148
[TBL] [Abstract][Full Text] [Related]
37. Radiotherapy combined with intratumoral dendritic cell vaccination enhances the therapeutic efficacy of adoptive T-cell transfer.
Teitz-Tennenbaum S; Li Q; Davis MA; Wilder-Romans K; Hoff J; Li M; Chang AE
J Immunother; 2009; 32(6):602-12. PubMed ID: 19483649
[TBL] [Abstract][Full Text] [Related]
38. BRAF inhibitor vemurafenib improves the antitumor activity of adoptive cell immunotherapy.
Koya RC; Mok S; Otte N; Blacketor KJ; Comin-Anduix B; Tumeh PC; Minasyan A; Graham NA; Graeber TG; Chodon T; Ribas A
Cancer Res; 2012 Aug; 72(16):3928-37. PubMed ID: 22693252
[TBL] [Abstract][Full Text] [Related]
39. CCR4 is critically involved in effective antitumor immunity in mice bearing intradermal B16 melanoma.
Matsuo K; Itoh T; Koyama A; Imamura R; Kawai S; Nishiwaki K; Oiso N; Kawada A; Yoshie O; Nakayama T
Cancer Lett; 2016 Aug; 378(1):16-22. PubMed ID: 27132989
[TBL] [Abstract][Full Text] [Related]
40. Low-dose total body irradiation facilitates antitumoral Th1 immune responses.
Sonanini D; Griessinger CM; Schörg BF; Knopf P; Dittmann K; Röcken M; Pichler BJ; Kneilling M
Theranostics; 2021; 11(16):7700-7714. PubMed ID: 34335959
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
